SMNROTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SMNRW
Semnur Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.43+0.03 (+6.75%)
Close on Oct 19, 2026
- Market cap
- $98.30M
- P/E (TTM)
- –
- Dividend yield
- –